MICM
TARO

Matthews International Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Matthews International Capital Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-144,612
Closed -$16.7M – 38
2018
Q2 		$16.7M Sell
144,612
-248,488
-63% -$27.3M 0.75% 17
2018
Q1 		$38.8M Sell
393,100
-54,400
-12% -$5.51M 1.76% 13
2017
Q4 		$46.9M Sell
447,500
-206,700
-32% -$22.7M 2.21% 13
2017
Q3 		$73.7M Sell
654,200
-151,600
-19% -$16.5M 3.05% 11
2017
Q2 		$90.3M Sell
805,800
-2,400
-0.3% -$271K 4.1% 9
2017
Q1 		$94.3M Hold
808,200
– – 4.8% 7
2016
Q4 		$85.1M Buy
808,200
+106,300
+15% +$11.1M 4.39% 8
2016
Q3 		$77.6M Buy
701,900
+171,800
+32% +$22.7M 3.19% 10
2016
Q2 		$77.2M Buy
530,100
+30,300
+6% +$4.3M 3.37% 11
2016
Q1 		$71.6M Sell
499,800
-27,466
-5% -$3.9M 3.18% 10
2015
Q4 		$81.5M Sell
527,266
-36,434
-6% -$5.32M 3.63% 11
2015
Q3 		$80.5M Sell
563,700
-7,000
-1% -$979K 3.57% 12
2015
Q2 		$82M Buy
570,700
+32,700
+6% +$4.66M 2.84% 12
2015
Q1 		$75.9M Buy
538,000
+498,304
+1,255% +$76.7M 2.65% 12
2014
Q4 		$5.88M Buy
+39,696
New +$5.83M 0.24% 25

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Matthews International Capital Management's TARO Position: Q3 2018 in Review

Matthews International Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018, closing a stake of 144,612 shares — an estimated $16.7M sold.

Matthews International Capital Management first reported a position in TARO in Q4 2014 and held it in 15 quarters. The position peaked at $94.3M in Q1 2017. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

  • Matthews International Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2018 after selling out during the quarter.
  • Matthews International Capital Management sold 144,612 Taro Pharmaceutical Industries Ltd. shares in Q3 2018, an estimated $16.7M.
  • Matthews International Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and held it in 15 quarters.
  • Matthews International Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $94.3M in Q1 2017.
  • 114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on Matthews International Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.